Skip to main content

Advertisement

Table 3 Mortality in IgA anti-tTG positive individuals (subgroup analyses)

From: Increased mortality among men aged 50 years old or above with elevated IgA anti-transglutaminase antibodies: NHANES III

Subgroup tTGA+ Deaths tTGA- Deaths Adjusted HR; 95 % CI P value Absolute risk/1000 PYAR Excess risk/1000 PYAR
Sex
 Males 44 1535 1.69; 1.26–2.29 0.001 96 39
 Females 14 1461 0.96; 0.57–1.62 0.881 42 −2
Age
 50–59 years 3 272 1.91; 0.61–6.02 0.267 21 10
 60–69 years 20 766 1.58; 1.01–2.47 0.044 54 20
 70–79 years 22 940 1.49; 0.97–2.27 0.068 103 34
 80+ years 13 1018 1.41; 0.81–2.47 0.222 217 63
Race
 Non-Hispanic White 29 1794 1.58; 1.09–2.28 0.015 77 28
 Non-Hispanic Black 13 603 1.25; 0.72–2.17 0.424 68 14
 Mexican-American 13 532 1.23; 0.71–2.15 0.461 68 13
 Other 3 67 4.75; 1.45–15.55 0.010 97 76
  1. Reference is general population comparator cohort
  2. tTGA tissue transglutaminase antibody, PYAR Person-years at risk